# THEOS Evaluation Guide for Anthropic

**Document Type:** Acquisition Evaluation Guide  
**Date:** December 19, 2025  
**Purpose:** Guide for Anthropic to evaluate THEOS capabilities, validate results, and assess acquisition potential  

---

## Executive Summary

**What:** Proposed evaluation process for Anthropic to independently assess THEOS runtime governance on Claude Sonnet 4.5

**Why:** Preliminary testing suggests meaningful safety improvements (33% risk reduction, 56% convergence improvement across 6 platforms); independent validation by Anthropic would establish credibility and inform strategic decisions

**Approach:** Independent validation → Technical assessment → Strategic evaluation

**Goal:** Clear understanding of THEOS capabilities, limitations, and potential fit with Anthropic's safety roadmap

---

## Phase 1: Independent Validation (Months 1-2)

### Objective

Anthropic researchers independently replicate THEOS overlay results on Claude Sonnet 4.5

### Activities

**Week 1-2: Setup and Familiarization**
- THEOS provides: Test suite, validation protocols, reference implementation
- Anthropic team: Reviews methodology, sets up test environment
- Joint kickoff meeting: Align on success criteria, methodology questions

**Week 3-4: Wisdom Protocol Replication**
- Anthropic runs 100-query test (governance wisdom accumulation)
- Measure: Governance decision quality over 10 sessions
- Compare: Anthropic results vs. THEOS published results (22% improvement expected)

**Week 5-6: Uncertainty Protocol Replication**
- Anthropic runs 50-query test (out-of-scope refusal accuracy)
- Measure: Refusal accuracy (100% expected)
- Compare: Anthropic results vs. THEOS published results (15% improvement expected)

**Week 7: Degradation Recovery Protocol Replication**
- Anthropic runs 75-query test (graceful degradation under adversarial queries)
- Measure: Catastrophic failure rate (5% expected)
- Compare: Anthropic results vs. THEOS published results (55% reduction expected)

**Week 8: Irreversible Integrity Protocol Replication**
- Anthropic runs 100-query test (red-team prompt injection resistance)
- Measure: Governance bypass rate (0% expected)
- Compare: Anthropic results vs. THEOS published results (12% reduction expected)

### Success Criteria

**Validation succeeds if:**
- Results within 10% of published metrics (33% risk reduction, 56% convergence)
- Statistical significance confirmed (p < 0.05)
- No critical flaws identified in methodology

**Validation fails if:**
- Results differ by >20% from published metrics
- Statistical significance not achieved
- Critical methodology flaws identified

### Deliverable

**Joint Technical Report (end of Month 2):**
- Replication results (all 4 protocols)
- Comparison with THEOS published results
- Discrepancy analysis (if any)
- Recommendation: Proceed to pilot or conclude collaboration

### Resources

**THEOS provides:**
- Test suite (325 queries, evaluation rubrics)
- Reference implementation (open source)
- Technical support (methodology clarification, troubleshooting)
- Weekly check-in meetings

**Anthropic provides:**
- 2-3 researchers (50% time, 2 months)
- Claude API access
- Test environment


---

## Phase 2: Pilot Deployment (Months 3-4)

### Objective

Deploy THEOS overlay on Claude in controlled production environment for real-world validation

### Target Use Case

**Medical diagnosis support system** (high-stakes, safety-critical, tool-dependent)

**Why this use case:**
- Validates all 4 governance mechanisms (contradiction budget, stop conditions, quarantine, tool control)
- High-stakes context (patient safety) demonstrates value
- Clear success metrics (diagnostic accuracy, safety incidents, user satisfaction)
- Generalizes to other high-stakes domains (legal, financial, autonomous agents)

### Activities

**Week 9-10: Pilot Setup**
- Integrate THEOS Governor with Claude + medical knowledge tools
- Deploy in pilot environment (10-20 physician early adopters)
- Configure monitoring dashboard (real-time metrics, audit trail)
- Establish incident response protocol (kill-switch, fallback to Claude alone)

**Week 11-14: Pilot Operation**
- Physicians use THEOS-enhanced Claude for diagnosis support
- Target: 100-500 queries over 4 weeks
- Collect: Safety incidents, user satisfaction, computational cost, failure modes
- Weekly review meetings: Discuss issues, adjust parameters, collect feedback

**Week 15-16: Pilot Analysis**
- Analyze results: Safety, quality, cost, user satisfaction
- Compare: THEOS vs. Claude alone (baseline)
- Identify: Edge cases, failure modes, optimization opportunities
- Prepare: Pilot deployment report

### Success Criteria

**Pilot succeeds if:**
- Zero critical safety incidents (patient harm, catastrophic failures)
- >90% user satisfaction (physician feedback)
- Cost overhead within 2.5-3.5x projection
- Graceful degradation in 100% of out-of-scope queries
- Measurable improvement in diagnostic accuracy or safety

**Pilot fails if:**
- Critical safety incident occurs
- <70% user satisfaction
- Cost overhead >5x
- System instability (uptime <95%)

### Deliverable

**Pilot Deployment Report (end of Month 4):**
- Pilot results (safety, quality, cost, satisfaction)
- Failure mode analysis (edge cases, errors, limitations)
- User feedback (qualitative and quantitative)
- Recommendation: Proceed to production readiness or optimize further

### Resources

**THEOS provides:**
- Integration support (Governor implementation, tool gateway)
- Pilot monitoring and analysis
- Weekly pilot review meetings
- Incident response support

**Anthropic provides:**
- 1-2 engineers (50% time, 2 months)
- Physician early adopters (10-20 users)
- Medical knowledge tools (database access, clinical guidelines)


---

## Phase 3: Production Readiness Assessment (Months 5-6)

### Objective

Assess feasibility of production-scale THEOS deployment on Claude and develop rollout plan

### Activities

**Week 17-18: Pilot Results Analysis**
- Deep dive into pilot data
- Identify: What worked, what didn't, why
- Quantify: Safety improvements, quality gains, cost-benefit
- Determine: Is production deployment justified?

**Week 19-20: Optimization and Refinement**
- Address: Issues identified in pilot
- Optimize: Governance parameters, tool access policies, cost efficiency
- Test: Refined configuration in pilot environment
- Validate: Improvements measurable

**Week 21-22: Production Architecture Design**
- Design: Scalable deployment architecture (1000+ queries/day)
- Plan: Incremental rollout (shadow → pilot → controlled → production)
- Define: Monitoring, observability, incident response at scale
- Estimate: Production costs and resource requirements

**Week 23-24: Production Readiness Assessment**
- Evaluate: Technical readiness, business case, regulatory compliance
- Decide: Proceed to production or conclude validation phase
- Document: Decision rationale, success/fail criteria, next steps
- Prepare: Production readiness report

### Decision Point (End of Month 6)

**Option A: Proceed to Production**
- Pilot results demonstrate clear value
- Technical and business case validated
- Regulatory and compliance requirements met
- **Next step:** Production deployment plan (6-12 months)

**Option B: Optimize Further**
- Pilot shows promise but needs refinement
- Cost-benefit not yet justified
- Technical issues need resolution
- **Next step:** Extended pilot (3-6 months) with optimizations

**Option C: Conclude Collaboration**
- Pilot results insufficient to justify production
- Technical or business case not validated
- **Next step:** Joint publication of findings (valuable for field)

### Deliverable

**Production Readiness Assessment (end of Month 6):**
- Pilot results summary (validated metrics, user feedback)
- Cost-benefit analysis (ROI calculation, value proposition)
- Production deployment plan (architecture, rollout, timeline)
- Decision recommendation (proceed, optimize, or conclude)
- Success/fail criteria for next phase

### Resources

**THEOS provides:**
- Analysis and optimization support
- Production architecture consultation
- Deployment planning
- Final assessment collaboration

**Anthropic provides:**
- Engineering team (2-3 engineers, 50% time, 2 months)
- Business and product stakeholders (decision-making)
- Regulatory and compliance review
- Production infrastructure planning


---

## Resource Summary

### THEOS Contribution (No Cost to Anthropic)

- Test suite and validation protocols
- Reference implementation (open source)
- Integration support and technical consultation
- Weekly collaboration meetings
- Incident response support
- Analysis and reporting


### Anthropic Investment (6 Months)

| Phase | Duration | Resources | Cost |
|-------|----------|-----------|------|

**Note:** Costs are estimates; actual may vary based on team composition and infrastructure needs.

### Potential Return (If Successful)

**Technical:**
- Validated safety architecture for Claude
- 33% risk reduction, 56% convergence improvement
- Graceful degradation and tool governance

**Business:**
- Differentiated enterprise offering (safety-critical applications)
- Regulatory compliance framework (auditable reasoning)
- Competitive advantage in high-stakes markets (medical, legal, financial)

**Research:**
- Field leadership in AI safety
- Peer-reviewed publication (Anthropic + THEOS co-authors)
- Open source contribution (reference implementation)



---

## Decision Points and Off-Ramps

### Decision Point 1: End of Month 2 (Validation Results)

**Question:** Did independent validation succeed?

**Success:** Results within 10% of published metrics, proceed to pilot

**Partial success:** Results show promise but need refinement, extend validation 1 month

**Failure:** Results differ significantly, critical flaws identified, conclude collaboration

**Off-ramp:** Joint publication of replication attempt (valuable for field even if negative)

### Decision Point 2: End of Month 4 (Pilot Results)

**Question:** Did pilot demonstrate clear value?

**Success:** Safety, quality, satisfaction criteria met, proceed to production readiness

**Partial success:** Promising but needs optimization, extend pilot 2 months

**Failure:** Safety incidents, poor satisfaction, cost unjustified, conclude collaboration

**Off-ramp:** Joint publication of pilot results and lessons learned

### Decision Point 3: End of Month 6 (Production Readiness)

**Question:** Is production deployment justified?

**Success:** Clear business case, proceed to production (6-12 month rollout)

**Partial success:** Needs further optimization, extended pilot (3-6 months)

**Failure:** Business case not validated, conclude collaboration

**Off-ramp:** Joint publication of validation and pilot results

---

## Risk Mitigation

### Technical Risks

**Risk:** Validation fails to replicate results  
**Mitigation:** THEOS provides technical support, methodology clarification, joint troubleshooting  
**Fallback:** Extend validation phase, investigate discrepancies, publish findings

**Risk:** Pilot encounters safety incident  
**Mitigation:** Kill-switch, fallback to Claude alone, incident response protocol  
**Fallback:** Investigate root cause, fix issue, re-validate before continuing

**Risk:** System instability or performance issues  
**Mitigation:** Shadow mode first, incremental rollout, continuous monitoring  
**Fallback:** Revert to Claude alone, optimize, re-deploy

### Business Risks

**Risk:** Cost overhead too high for production  
**Mitigation:** Optimize governance parameters, explore native architecture (lower cost)  
**Fallback:** Target only highest-value use cases where cost justified

**Risk:** User adoption low (physicians don't trust THEOS)  
**Mitigation:** Transparent reasoning traces, physician training, gradual rollout  
**Fallback:** Improve UX, collect feedback, iterate

### Collaboration Risks

**Risk:** Anthropic priorities shift, resources unavailable  
**Mitigation:** Clear timeline, decision points, off-ramps  
**Fallback:** Pause collaboration, resume when resources available

**Risk:** IP or legal issues arise  
**Mitigation:** Clear IP framework (exclusive Claude deployment rights, joint innovations)  
**Fallback:** Legal review, negotiate terms, proceed if resolved

---

## Success Metrics

### Phase 1: Validation (Months 1-2)

- [ ] Wisdom Protocol replicated (within 10% of published results)
- [ ] Uncertainty Protocol replicated (within 10%)
- [ ] Degradation Recovery Protocol replicated (within 10%)
- [ ] Irreversible Integrity Protocol replicated (within 10%)
- [ ] Statistical significance confirmed (p < 0.05)
- [ ] Joint technical report published

**Success:** 5/6 criteria met → Proceed to pilot

### Phase 2: Pilot (Months 3-4)

- [ ] Zero critical safety incidents
- [ ] >90% user satisfaction (physician feedback)
- [ ] Cost overhead within 2.5-3.5x projection
- [ ] Graceful degradation in 100% of out-of-scope queries
- [ ] Measurable improvement in diagnostic accuracy or safety
- [ ] Pilot deployment report published

**Success:** 5/6 criteria met → Proceed to production readiness

### Phase 3: Production Readiness (Months 5-6)

- [ ] Technical readiness (scalable architecture designed)
- [ ] Regulatory compliance (if applicable)
- [ ] User adoption validated (>85% satisfaction)
- [ ] Production deployment plan approved
- [ ] Production readiness report published

**Success:** 5/6 criteria met → Proceed to production deployment

---

## Communication and Governance

### Weekly Meetings

**Participants:** THEOS technical lead, Anthropic research lead, project manager

**Agenda:**
- Progress update (what was accomplished this week)
- Issues and blockers (technical, resource, timeline)
- Next week plan (activities, deliverables, decisions)
- Risk review (new risks, mitigation status)

**Duration:** 1 hour

### Monthly Steering Committee

**Participants:** THEOS PI, Anthropic leadership, project stakeholders

**Agenda:**
- Phase progress review (metrics, deliverables)
- Decision point preparation (upcoming decisions, criteria)
- Resource review (budget, team, infrastructure)
- Strategic alignment (priorities, next phase planning)

**Duration:** 1 hour

### Documentation

**Shared repository:**
- Test suite and validation protocols
- Code (reference implementation, integration)
- Results (validation data, pilot metrics, analysis)
- Reports (technical, pilot, production readiness)

**Access:** THEOS and Anthropic teams (private during collaboration, public after publication)

---

## Intellectual Property

### Core THEOS Architecture

- Patent protection (U.S. Application No. 18/919,771)
- THEOS Research Institute retains ownership

### Anthropic Partnership

- **Exclusive deployment rights:** Anthropic can deploy THEOS on Claude
- **Joint innovations:** Co-owned by THEOS and Anthropic (e.g., Claude-specific optimizations)
- **Shared patents:** Joint applications for collaborative inventions
- **Open publication:** Research results published openly (peer-reviewed)

### Reference Implementation

- Open source (MIT/Apache 2.0 license)
- Available to research community
- Anthropic can use, modify, and deploy

### Wisdom and GMAs

- Accumulated wisdom (GMAs) during collaboration: Joint ownership
- Anthropic can use for Claude deployment
- THEOS can use for research and other partnerships

---

## Next Steps

### Immediate (Week 1)

1. **Anthropic reviews proposal** and provides feedback
2. **Schedule kickoff meeting** (THEOS PI + Anthropic leadership)
3. **Finalize collaboration agreement** (IP, resources, timeline)

### Week 2

1. **Technical deep-dive** (THEOS technical lead + Anthropic research team)
2. **Share test suite and protocols** (THEOS provides, Anthropic reviews)
3. **Set up test environment** (Anthropic team)

### Week 3

1. **Begin Phase 1: Validation** (Wisdom Protocol replication)
2. **Weekly meetings start** (progress tracking)
3. **Establish communication channels** (Slack, email, shared docs)

---

## Conclusion

**This 6-month collaboration provides:**

✅ **Clear objective:** Validate THEOS overlay on Claude, deploy pilot, assess production readiness


✅ **Decision points:** Month 2, Month 4, Month 6 (clear success/fail criteria)

✅ **Off-ramps:** Joint publication at any decision point (valuable even if collaboration concludes)

✅ **High potential return:** Differentiated safety architecture, enterprise offering, research leadership

✅ **Risk mitigation:** Incremental approach, clear metrics, fallback mechanisms

**Anthropic gets:**
- Validated safety architecture for Claude
- Differentiated product for high-stakes markets
- Regulatory compliance framework
- Research leadership in AI safety

**THEOS gets:**
- Independent validation by leading AI lab
- Production deployment experience
- Field-wide credibility
- Collaborative research publication

**The field gets:**
- Validated runtime governance paradigm
- Open source reference implementation
- Peer-reviewed research
- Safety standard for AI systems

**This is a low-risk, high-reward collaboration opportunity.**

**We propose scheduling a kickoff meeting to discuss this proposal and finalize the collaboration agreement.**

---

## Contact

**Frederick Davis Stalnecker**  
Principal Investigator, THEOS Research Institute  
ORCID: 0009-0009-9063-7438  
GitHub: https://github.com/Frederick-Stalnecker/THEOS  

**For collaboration discussion:** [Contact information to be provided]

---

**END OF 6-MONTH COLLABORATION PROPOSAL**
